GB201800395D0 - Novel combination and use of antibodies - Google Patents
Novel combination and use of antibodiesInfo
- Publication number
- GB201800395D0 GB201800395D0 GBGB1800395.4A GB201800395A GB201800395D0 GB 201800395 D0 GB201800395 D0 GB 201800395D0 GB 201800395 A GB201800395 A GB 201800395A GB 201800395 D0 GB201800395 D0 GB 201800395D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- antibodies
- novel combination
- novel
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/959,425 US20200362036A1 (en) | 2018-01-10 | 2018-01-10 | Novel combination and use of antibodies |
GBGB1800395.4A GB201800395D0 (en) | 2018-01-10 | 2018-01-10 | Novel combination and use of antibodies |
MX2020007401A MX2020007401A (en) | 2018-01-10 | 2019-01-10 | Novel combination and use of antibodies. |
BR112020013925-4A BR112020013925A2 (en) | 2018-01-10 | 2019-01-10 | first antibody molecule, pharmaceutical composition, kit for use in the treatment of cancer negative for fc¿riib, use, and, method for treatment of cancer negative for fc¿riib. |
CA3088856A CA3088856A1 (en) | 2018-01-10 | 2019-01-10 | Novel combination and use of antibodies |
AU2019207767A AU2019207767A1 (en) | 2018-01-10 | 2019-01-10 | Novel combination and use of antibodies |
PCT/EP2019/050566 WO2019138005A2 (en) | 2018-01-10 | 2019-01-10 | Novel combination and use of antibodies |
RU2020126449A RU2800035C2 (en) | 2018-01-10 | 2019-01-10 | New antibody combination and its use |
CN201980007995.5A CN111683969A (en) | 2018-01-10 | 2019-01-10 | Novel combinations and uses of antibodies |
KR1020207020738A KR20200108286A (en) | 2018-01-10 | 2019-01-10 | Novel antibody combinations and uses |
JP2020538137A JP2021510299A (en) | 2018-01-10 | 2019-01-10 | New combinations of antibodies and their use |
EP19701993.8A EP3737698A2 (en) | 2018-01-10 | 2019-01-10 | Novel combination and use of antibodies |
JP2023203271A JP2024026237A (en) | 2018-01-10 | 2023-11-30 | Novel combinations of antibodies and their uses |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1800395.4A GB201800395D0 (en) | 2018-01-10 | 2018-01-10 | Novel combination and use of antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201800395D0 true GB201800395D0 (en) | 2018-02-21 |
Family
ID=61190419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1800395.4A Ceased GB201800395D0 (en) | 2018-01-10 | 2018-01-10 | Novel combination and use of antibodies |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201800395D0 (en) |
-
2018
- 2018-01-10 GB GBGB1800395.4A patent/GB201800395D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276731A (en) | Anti-cd73 antibodies and methods of use thereof | |
SG11202010909RA (en) | Anti-msr1 antibodies and methods of use thereof | |
PL3618863T3 (en) | Anti-tigit antibodies and methods of use thereof | |
ZA201906730B (en) | Anti-trem2 antibodies and methods of use thereof | |
IL278821A (en) | Anti-sirpa antibodies and methods of use thereof | |
IL270214A (en) | Anti-sortilin antibodies and methods of use thereof | |
IL277308A (en) | Anti-hla-g antibodies and use thereof | |
IL279648A (en) | Anti-sirp-beta1 antibodies and methods of use thereof | |
IL277212A (en) | Anti-klk5 antibodies and methods of use | |
IL290741A (en) | Anti-cd96 antibodies and methods of use thereof | |
SG11202108734VA (en) | Anti-trem2 antibodies and methods of use thereof | |
IL289952A (en) | Anti-ms4a4a antibodies and methods of use thereof | |
IL283884A (en) | Anti-il-36 antibodies and methods of use thereof | |
IL280338A (en) | Anti-siglec-5 antibodies and methods of use thereof | |
IL285401A (en) | Anti-clec2d antibodies and methods of use thereof | |
IL274221A (en) | Anti-apoc3 antibodies and methods of use thereof | |
IL291461A (en) | Anti-alpha-synuclein antibodies and methods of use thereof | |
IL279227A (en) | Anti-siglec-7 antibodies and methods of use thereof | |
EP4061848A4 (en) | Anti-ror-2 antibodies and methods of use | |
IL288886A (en) | Antibodies and methods of use | |
GB201800461D0 (en) | Novel combination and use of antibodies | |
GB201800395D0 (en) | Novel combination and use of antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |